| Business Summary | | TCPI,
Inc.
markets
point-of-care
medical
diagnostic
products
for
use
at
home,
in
physician
offices,
and
other
healthcare
locations
and
distributes
them
worldwide
through
multiple
channels
under
its
HealthCheck
brand
as
well
as
original
equipment
manufacturer
and
private
label
programs.
The
Company
also
markets
its
patented
SR-38
skin
permeation
enhancer
and
owns
a
patent-protected,
proprietary
portfolio
of
transdermal
and
dermal
drug
delivery
technologies.
In
addition,
the
Company
manufactures
high
purity
specialty
biochemicals.
In
July
2001,
the
Company
filed
a
voluntary
petition
under
Chapter
11
of
the
U.S.
Bankruptcy
Code
with
the
U.S.
Bankruptcy
Court
in
the
Southern
District
of
Florida. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | TCPI
designs,
develops,
manufactures,
and
markets
membrane-based
diagnostic
devices.
TCPI
also
engages
in
the
research,
development
and
commercialization
of
transdermal
and
mucosal
drug
delivery
systems
and
skin
permeation
enhancer.
For
the
six
months
ended
6/01,
net
sales
rose
41%
to
$3.3
million.
Net
loss
applicable
to
Common
fell
44%
to
$2.6
million.
Results
reflect
increased
sales
of
the
SR-38
skin
permeation
enhancer,
and
ongoing
cost
containment
efforts. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Martin Gurkin, Ph.D., 68 Chairman | -- | Elliott Block, Ph.D., 56 Pres,
CEO, Director | $202K | Walter Usinowicz, Jr., 53 VP
of Fin., CFO | 135K | Jay Eckhaus, 56 VP,
Gen. Counsel, Sec. | 131K | Robert Morrow, 63 VP
of Sales and Marketing | 130K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|